rawfin.tv
Tango Therapeutics Shares Jump 53% on Positive Pancreatic Cancer Data
Marketsstocks🟠 Score 8AI Generated

Tango Therapeutics Shares Jump 53% on Positive Pancreatic Cancer Data

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Tango Therapeutics stock surged over 50% after the biotech firm released initial, "unprecedented" data from its ongoing study for a pancreatic cancer treatment. The positive results indicate significant progress in its clinical development program.

Tango TherapeuticsBiotechClinical TrialsPancreatic CancerDrug Development

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks